Minimal residual disease after radical surgery in EGFR-mutant non-small cell lung cancer

Ítems similars

• Targeting minimal residual disease after surgery with molecular targeted therapy: the real path to a cure?
  per: Masago, Katsuhiro, et al.
  Publicat: (2018)
• Not like breast cancer, but like breast cancer: micrometastasis and micropapillary structure in lung cancer
  per: Masago, Katsuhiro, et al.
  Publicat: (2017)
• A Rapid, Sensitive Assay to Detect EGFR Mutation in Small Biopsy Specimens from Lung Cancer
  per: Yatabe, Yasushi, et al.
  Publicat: (2006)
• Biopsy of palliative lesions following radiotherapy
  per: Fujita, Shiro, et al.
  Publicat: (2019)
• Alteration of DNA mismatch repair capacity underlying the co-occurrence of non-small-cell lung cancer and nonmedullary thyroid cancer
  per: Fujita, Shiro, et al.
  Publicat: (2021)